WHO ICTRP trial
A long-term extension study of AG-1749 in patients on concomitant long-term…
JPRN-jRCT2080220831 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080220831 |
|---|---|
| Public title | A long-term extension study of AG-1749 in patients on concomitant long-term non-steroidal antiinflammatory drug (NSAIDs) use |
| Scientific title | A long-term extension study of AG-1749 in patients on concomitant long-term non-steroidal antiinflammatory drug (NSAIDs) use |
| Primary sponsor | Takeda Pharmaceutical Company Limited |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Prevention of ulcer associated with NSAIDs |
| Interventions | investigational material(s) Generic name etc : AG-1749 INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material : Oral administration |
| Registration date | Aug 26, 2009 |
| Secondary IDs | JapicCTI-090862 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: